LEMTRADA
ALEMTUZUMAB
- Strength
- 12 mg/1.2mL
- Form
- Injection, Solution, Concentrate
- Class
- CD52-directed Cytolytic Antibody
Genzyme Corporation
Not stocked by us — reference only
ALEMTUZUMAB
Listed by Genzyme Corporation
| Dosage form | Injection |
|---|---|
| Route | Intravenous |
| Drug class | CD52-directed Cytolytic Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 58468-0357 |
| FDA application | BLA103948 |
| RxNorm concept | 828265 |
| Package sizes listed | 2 |
| Marketed since | November 2009 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ALEMTUZUMAB
Genzyme Corporation
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.